- Home
- SUPN vs ARHS Comparison
SUPN vs ARHS Comparison
Compare SUPN & ARHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- ARHS
- Stock Information
- Founded
- SUPN 2005
- ARHS 1986
- Country
- SUPN United States
- ARHS United States
- Employees
- SUPN N/A
- ARHS N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- ARHS Other Specialty Stores
- Sector
- SUPN Health Care
- ARHS Consumer Discretionary
- Exchange
- SUPN Nasdaq
- ARHS Nasdaq
- Market Cap
- SUPN 1.7B
- ARHS 1.7B
- IPO Year
- SUPN 2012
- ARHS 2021
- Fundamental
- Price
- SUPN $32.90
- ARHS $9.47
- Analyst Decision
- SUPN Hold
- ARHS Buy
- Analyst Count
- SUPN 2
- ARHS 12
- Target Price
- SUPN $36.00
- ARHS $12.38
- AVG Volume (30 Days)
- SUPN 787.3K
- ARHS 2.8M
- Earning Date
- SUPN 05-07-2025
- ARHS 05-08-2025
- Dividend Yield
- SUPN N/A
- ARHS N/A
- EPS Growth
- SUPN 6500.00
- ARHS N/A
- EPS
- SUPN 1.32
- ARHS 0.49
- Revenue
- SUPN $661,817,000.00
- ARHS $1,271,107,000.00
- Revenue This Year
- SUPN N/A
- ARHS $10.22
- Revenue Next Year
- SUPN $8.67
- ARHS $8.28
- P/E Ratio
- SUPN $24.90
- ARHS $20.13
- Revenue Growth
- SUPN 8.94
- ARHS N/A
- 52 Week Low
- SUPN $25.53
- ARHS $8.30
- 52 Week High
- SUPN $40.28
- ARHS $19.81
- Technical
- Relative Strength Index (RSI)
- SUPN 46.17
- ARHS 45.45
- Support Level
- SUPN $31.69
- ARHS $8.91
- Resistance Level
- SUPN $32.90
- ARHS $9.94
- Average True Range (ATR)
- SUPN 0.96
- ARHS 0.52
- MACD
- SUPN 0.29
- ARHS 0.14
- Stochastic Oscillator
- SUPN 89.25
- ARHS 71.03
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About ARHS Arhaus Inc.
Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in a number of categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and eCommerce sales channels.